Hydreight Technologies Inc. Stock
Equities
NURS
CA44877L1013
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.650 CAD | 0.00% |
|
-2.92% | -1.69% |
| 12-31 | Hydreight Technologies Enters At-Home STI Testing Market | MT |
| 12-31 | Hydreight Technologies Enters the At-Home STI Testing Market with Exclusive Distribution and 50,000 Pre-Orders | CI |
| Capitalization | 231M 166M 143M 133M 124M 15B 249M 1.53B 601M 7.17B 623M 610M 26.44B | P/E ratio 2025 * |
155x | P/E ratio 2026 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise value | 231M 166M 143M 133M 124M 15B 249M 1.53B 601M 7.17B 623M 610M 26.44B | EV / Sales 2025 * |
6.52x | EV / Sales 2026 * | 2.19x |
| Free-Float |
35.09% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Hydreight Technologies Inc.
More press releases
| 1 week | -2.92% | ||
| Current month | -1.69% | ||
| 1 month | +5.68% | ||
| 3 months | +12.86% | ||
| 6 months | +122.49% | ||
| Current year | -1.69% |
| 1 week | 4.6 |  | 4.93 |
| 1 month | 3.89 | | 5.09 |
| Current year | 4.55 | | 5.09 |
| 1 year | 1 | | 5.59 |
| 3 years | 0.2 | | 5.59 |
| 5 years | 0.2 | | 5.59 |
| 10 years | 0.2 | | 5.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shane Madden
CEO | Chief Executive Officer | - | 28/11/2022 |
Joshua Sorin
DFI | Director of Finance/CFO | - | 28/11/2022 |
Abbey Vogt
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gabriel Kabazo
BRD | Director/Board Member | 52 | 28/11/2022 |
Carey Dillen
BRD | Director/Board Member | 54 | 28/11/2022 |
Shafin Tejani
BRD | Director/Board Member | 49 | 29/11/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.92% | +102.17% | +730.36% | 166M | |
| -0.51% | -4.59% | +8.30% | +39.56% | 37.56B | |
| +1.31% | -0.63% | -16.38% | +260.26% | 14.62B | |
| -0.73% | -3.56% | -6.29% | +46.85% | 4.89B | |
| +8.72% | +43.09% | - | - | 3.8B | |
| -0.69% | -3.31% | - | - | 2.73B | |
| -1.04% | +7.67% | +20.72% | -11.29% | 2.31B | |
| +8.53% | +18.30% | - | - | 2.4B | |
| -0.19% | +29.53% | +23.47% | - | 1.66B | |
| +0.81% | +18.06% | +51.83% | -24.54% | 1.37B | |
| Average | +1.62% | +10.47% | +26.26% | +173.53% | 7.15B | |
| Weighted average by Cap. | +0.67% | +1.44% | +3.46% | +91.62% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 35.37M 25.46M 21.88M 20.4M 18.96M 2.3B 38.14M 235M 92.16M 1.1B 95.48M 93.52M 4.05B | 105M 75.92M 65.24M 60.84M 56.53M 6.86B 114M 699M 275M 3.28B 285M 279M 12.08B |
| Net income | 1.43M 1.03M 882K 822K 764K 92.68M 1.54M 9.45M 3.71M 44.29M 3.85M 3.77M 163M | 14.08M 10.13M 8.71M 8.12M 7.54M 915M 15.18M 93.35M 36.68M 437M 38M 37.22M 1.61B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
-
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/26 | 4.650 $ | 0.00% | 108,042 |
| 13/01/26 | 4.650 $ | -3.33% | 66,441 |
| 12/01/26 | 4.810 $ | +4.57% | 131,651 |
| 09/01/26 | 4.600 $ | -2.75% | 37,675 |
| 08/01/26 | 4.730 $ | -1.25% | 50,780 |
Delayed Quote Toronto S.E., January 14, 2026 at 06:32 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.650CAD
Average target price
8.500CAD
Spread / Average Target
+82.80%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NURS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition